EGRX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: EGRX Shares Outstanding History and EGRX YTD Return |
EGRX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: EGRX Shares Outstanding History and EGRX YTD Return |
EGRX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+8.30% CAGR Mouse over chart for data details
|
EGRX Stock Price Chart |
About Eagle Pharmaceuticals, Inc. |
Eagle Pharmaceuticals is an integrated pharmaceutical company with research and development, clinical, manufacturing and commercial capabilities. Co.'s products and product portfolio include: BARHEMSYS® (amisulpride for injection), which is for the treatment of postoperative nausea and vomiting; BYFAVO® (remimazolam for injection), which is indicated for the induction and maintenance of procedural sedation; bendamustine ready-to-dilute (RTD) 500ml solution, infused bendamustine RTD, and bendamustine RTD and infused RTD in Japan for Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma; Ryanodex® (dantrolene sodium) for Malignant Hyperthermia; and EA-114 (fulvestrant) for breast cancer. We show 40 historical shares outstanding datapoints in our EGRX shares outstanding history coverage, used to compute EGRX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing EGRX market cap history over the course of time is important for investors interested in comparing EGRX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of EGRX versus a peer is one thing; comparing EGRX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like EGRX can fluctuate over the course of history. With this page we aim to empower investors researching EGRX by allowing them to research the EGRX market cap history. |
EGRX Current Stock Quote |
Free EGRX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
EGRX Share Performance |
Market Cap Peers |
Eagle Pharmaceuticals (EGRX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
EHAB Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.